Difference between revisions of "Ibandronate (Boniva)"
Jump to navigation
Jump to search
m |
Warner-admin (talk | contribs) m (Text replacement - "please refer to your preferred pharmacopeias such as [http://www.thomsonhc.com/home/dispatch Micromedex], [https://online.lexi.com/lco/action/login UpToDate Lexidrug], [http://www.utdol.com/online/content/search.do UpToDate (courtesy of Lexicomp)], or the prescribing information" to "please refer to your preferred pharmacopeias or the prescribing information") |
||
| (10 intermediate revisions by 3 users not shown) | |||
| Line 1: | Line 1: | ||
| − | |||
| − | |||
==General information== | ==General information== | ||
| − | Class: Bisphosphonate, inhibits osteoclast activity, dissolution of hydroxyapatite crystals, and bone resorption/turnover.<ref name="insert">[http://www.gene.com/download/pdf/boniva_tablets_prescribing.pdf Ibandronate (Boniva) package insert]</ref><ref>[[ | + | Class/mechanism: Bisphosphonate, inhibits osteoclast activity, dissolution of hydroxyapatite crystals, and bone resorption/turnover.<ref name="insert">[http://www.gene.com/download/pdf/boniva_tablets_prescribing.pdf Ibandronate (Boniva) package insert]</ref><ref>[[:File:Ibandronate.pdf | Ibandronate (Boniva) package insert (locally hosted backup)]]</ref><ref name="injection">[http://www.gene.com/download/pdf/boniva_injection_prescribing.pdf Ibandronate injection (Boniva injection) package insert]</ref><ref>[[:File:Ibandronateinjection.pdf | Ibandronate injection (Boniva injection) package insert (locally hosted backup)]]</ref><ref>[http://www.gene.com/patients/medicines/boniva-tablets Boniva manufacturer's website]</ref> |
<br>Route: PO, IV | <br>Route: PO, IV | ||
<br>Extravasation: no information | <br>Extravasation: no information | ||
| − | For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. | + | For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias or the prescribing information.<ref name="insert"></ref> |
==Patient drug information== | ==Patient drug information== | ||
| Line 13: | Line 11: | ||
*Patient counseling information can be found on [http://www.gene.com/download/pdf/boniva_injection_prescribing.pdf#page=18 page 18-21 of the Ibandronate injection (Boniva injection) package insert]<ref name="injection"></ref> | *Patient counseling information can be found on [http://www.gene.com/download/pdf/boniva_injection_prescribing.pdf#page=18 page 18-21 of the Ibandronate injection (Boniva injection) package insert]<ref name="injection"></ref> | ||
*[http://www.uptodate.com/contents/ibandronate-patient-drug-information Ibandronate (Boniva) patient drug information (UpToDate)]<ref>[http://www.uptodate.com/contents/ibandronate-patient-drug-information Ibandronate (Boniva) patient drug information (UpToDate)]</ref> | *[http://www.uptodate.com/contents/ibandronate-patient-drug-information Ibandronate (Boniva) patient drug information (UpToDate)]<ref>[http://www.uptodate.com/contents/ibandronate-patient-drug-information Ibandronate (Boniva) patient drug information (UpToDate)]</ref> | ||
| + | |||
| + | ==Also known as== | ||
| + | *'''Generic names:''' ibandronate sodium, ibandronic acid | ||
| + | *'''Brand names:''' Bandrobon, Bandrone, Bondenza, Bondronat, Boniva, Bonviva, Femorel | ||
==References== | ==References== | ||
<references/> | <references/> | ||
| − | [[Category: | + | [[Category:Drugs]] |
| + | [[Category:Intravenous medications]] | ||
| + | [[Category:Oral medications]] | ||
[[Category:Bisphosphonates]] | [[Category:Bisphosphonates]] | ||
| + | |||
| + | [[Category:FDA approved in 2003]] | ||
Latest revision as of 01:05, 29 June 2024
General information
Class/mechanism: Bisphosphonate, inhibits osteoclast activity, dissolution of hydroxyapatite crystals, and bone resorption/turnover.[1][2][3][4][5]
Route: PO, IV
Extravasation: no information
For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias or the prescribing information.[1]
Patient drug information
- Patient counseling information can be found on page 17-21 of the Ibandronate (Boniva) package insert[1]
- Patient counseling information can be found on page 18-21 of the Ibandronate injection (Boniva injection) package insert[3]
- Ibandronate (Boniva) patient drug information (UpToDate)[6]
Also known as
- Generic names: ibandronate sodium, ibandronic acid
- Brand names: Bandrobon, Bandrone, Bondenza, Bondronat, Boniva, Bonviva, Femorel
References
- ↑ 1.0 1.1 1.2 Ibandronate (Boniva) package insert
- ↑ Ibandronate (Boniva) package insert (locally hosted backup)
- ↑ 3.0 3.1 Ibandronate injection (Boniva injection) package insert
- ↑ Ibandronate injection (Boniva injection) package insert (locally hosted backup)
- ↑ Boniva manufacturer's website
- ↑ Ibandronate (Boniva) patient drug information (UpToDate)